Skip to main content
. 2016 Jun 17;311(2):L238–L254. doi: 10.1152/ajplung.00142.2016

Fig. 8.

Fig. 8.

Changes in microRNA (miR) expression during the development of fibrosis. A: immunoblot for BMPR2 and β-actin for PBS, BLM day 14 (D14), BLM day 21 (D21), and BLM day 25 (D25) treatment groups. Expression levels of miR-7 (B), miR-21 (C), miR-23a (D), miR-23b (E), miR-130 (F), miR-130b (G), miR-181 (H), and miR-26 (I), using U6 small nuclear RNA as a control from PBS, BLM day 14 BLM day 21 and BLM day 25 treatment groups. **0.001 < P < 0.01, ***P ≤ 0.01, ANOVA comparisons between PBS and BLM treatment groups.